STAAR Surgical | STAA - Equity Capital And Reserves


STAAR Surgical reported $376.13M in Equity Capital and Reserves for its fiscal quarter ending in September of 2026.





Equity Capital And Reserves Change Date
Abbott USD 51.03B 83M Sep/2026
Bausch Health Companies USD -341M 461M Sep/2026
Boston Scientific USD 25.63B 700M Sep/2026
Cerus USD 64.22M 2.76M Dec/2025
Cooper Companies USD 8.33B 89.1M Jun/2026
J&J USD 81.53B 3.44B Sep/2026
Merit Medical Systems USD 1.74B 64.75M Sep/2026
Novartis USD 37.23B 4.72B Sep/2026
OraSure Technologies USD 317.78M 4.45M Jun/2026
Orthofix International USD 429.18M 6.01M Jun/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 376.13M 10.73M Sep/2026
Utah Medical Products USD 120.37M 1.1M Mar/2026